Search results for: 'termination code out of contract'

The market for Energy Performance Contracting (EPC) for buildings in the United Arab Emirates (UAE) and the Kingdom of Saudi Arabia (KSA) is in early stages of development. However, both countries are making significant progress in not only diversifying their economies toward lesser dependence on oil but also toward more environmental sustainabilit...

Automotive sales in 2021 continued the seismic shift to electric vehicles (EV) that began in 2020, defying even the most bullish estimates as global EV sales grew by more than 100% year over year (YoY) with close to 6.7 million units sold to achieve 8.9% penetration in the passenger car market. China and Europe led the way, closely followed by the ...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

This edition of IT, Computing and Communications (ITCC) Technology Opportunity Engine (TOE) captures developments related to Hyper-Distributed Edge Cloud, Edge AI Orchestration, Edge IoT, Real Time Analytics, Marketplace, Application Risk, 5G Data Management, AI Voice, Private Network PaaS, No-Code Workflow Automation, Vision AI, Digital Learning a...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...

This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO s...

11 Nov 2022  |  North America  |  Market Research

Global Contract Research Organization (CRO) Growth Opportunities

Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

Infographics

×

Key Issues Addressed

The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...